Skip to main content
Top
Published in: BMC Health Services Research 1/2012

Open Access 01-12-2012 | Research article

Empirical analysis shows reduced cost data collection may be an efficient method in economic clinical trials

Authors: Hildegard Seidl, Christa Meisinger, Rupert Wende, Rolf Holle

Published in: BMC Health Services Research | Issue 1/2012

Login to get access

Abstract

Background

Data collection for economic evaluation alongside clinical trials is burdensome and cost-intensive. Limiting both the frequency of data collection and recall periods can solve the problem. As a consequence, gaps in survey periods arise and must be filled appropriately. The aims of our study are to assess the validity of incomplete cost data collection and define suitable resource categories.

Methods

In the randomised KORINNA study, cost data from 234 elderly patients were collected quarterly over a 1-year period. Different strategies for incomplete data collection were compared with complete data collection. The sample size calculation was modified in response to elasticity of variance.

Results

Resource categories suitable for incomplete data collection were physiotherapy, ambulatory clinic in hospital, medication, consultations, outpatient nursing service and paid household help.
Cost estimation from complete and incomplete data collection showed no difference when omitting information from one quarter. When omitting information from two quarters, costs were underestimated by 3.9% to 4.6%.
With respect to the observed increased standard deviation, a larger sample size would be required, increased by 3%. Nevertheless, more time was saved than extra time would be required for additional patients.

Conclusion

Cost data can be collected efficiently by reducing the frequency of data collection. This can be achieved by incomplete data collection for shortened periods or complete data collection by extending recall windows. In our analysis, cost estimates per year for ambulatory healthcare and non-healthcare services in terms of three data collections was as valid and accurate as a four complete data collections. In contrast, data on hospitalisation, rehabilitation stays and care insurance benefits should be collected for the entire target period, using extended recall windows. When applying the method of incomplete data collection, sample size calculation has to be modified because of the increased standard deviation. This approach is suitable to enable economic evaluation with lower costs to both study participants and investigators.

Trial registration

The trial registration number is ISRCTN02893746
Appendix
Available only for authorised users
Literature
1.
go back to reference Breyer F, Felder S: Life expectancy and health care expenditures: a new calculation for Germany using the costs of dying. Health Policy. 2006, 75 (2): 178-186. 10.1016/j.healthpol.2005.03.011.CrossRefPubMed Breyer F, Felder S: Life expectancy and health care expenditures: a new calculation for Germany using the costs of dying. Health Policy. 2006, 75 (2): 178-186. 10.1016/j.healthpol.2005.03.011.CrossRefPubMed
2.
go back to reference Schulz E, Leidl R, Konig HH: The impact of ageing on hospital care and long-term care–the example of Germany. Health Policy. 2004, 67 (1): 57-74. 10.1016/S0168-8510(03)00083-6.CrossRefPubMed Schulz E, Leidl R, Konig HH: The impact of ageing on hospital care and long-term care–the example of Germany. Health Policy. 2004, 67 (1): 57-74. 10.1016/S0168-8510(03)00083-6.CrossRefPubMed
3.
go back to reference Seshamani M, Gray A: Ageing and health-care expenditure: the red herring argument revisited. Health Econ. 2004, 13 (4): 303-314. 10.1002/hec.826.CrossRefPubMed Seshamani M, Gray A: Ageing and health-care expenditure: the red herring argument revisited. Health Econ. 2004, 13 (4): 303-314. 10.1002/hec.826.CrossRefPubMed
4.
go back to reference Cost-effectiveness in health and medicine. Edited by: Gold MR, Siegel JE, Russell LB, Weinstein MC. 1996, New York: Oxford University Press Cost-effectiveness in health and medicine. Edited by: Gold MR, Siegel JE, Russell LB, Weinstein MC. 1996, New York: Oxford University Press
5.
go back to reference Ramsey SD, McIntosh M, Sullivan SD: Design issues for conducting cost-effectiveness analyses alongside clinical trials. Annu Rev Public Health. 2001, 22: 129-141. 10.1146/annurev.publhealth.22.1.129.CrossRefPubMed Ramsey SD, McIntosh M, Sullivan SD: Design issues for conducting cost-effectiveness analyses alongside clinical trials. Annu Rev Public Health. 2001, 22: 129-141. 10.1146/annurev.publhealth.22.1.129.CrossRefPubMed
6.
go back to reference Glick H, Doshi JA, Sonnad SS, Polsky D: Economic evaluation in clinical trials. Handbooks in health economic evaluation series. Edited by: Gray A, Briggs A. 2007, Oxford University Press, New York Glick H, Doshi JA, Sonnad SS, Polsky D: Economic evaluation in clinical trials. Handbooks in health economic evaluation series. Edited by: Gray A, Briggs A. 2007, Oxford University Press, New York
7.
go back to reference Schulman KA, Glick H, Buxton M, Sculpher M, Backhouse M, Bell L, Eisenberg JM: The economic evaluation of the first study: design of a prospective analysis alongside a multinational phase III clinical trial. Flolan international randomized survival trial. Control Clin Trials. 1996, 17 (4): 304-315. 10.1016/0197-2456(95)00166-2.CrossRefPubMed Schulman KA, Glick H, Buxton M, Sculpher M, Backhouse M, Bell L, Eisenberg JM: The economic evaluation of the first study: design of a prospective analysis alongside a multinational phase III clinical trial. Flolan international randomized survival trial. Control Clin Trials. 1996, 17 (4): 304-315. 10.1016/0197-2456(95)00166-2.CrossRefPubMed
8.
go back to reference Ridyard CH, Hughes DA: Methods for the collection of resource use data within clinical trials: a systematic review of studies funded by the UK health technology assessment program. Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research. 2010, 13 (8): 867-872. 10.1111/j.1524-4733.2010.00788.x.CrossRef Ridyard CH, Hughes DA: Methods for the collection of resource use data within clinical trials: a systematic review of studies funded by the UK health technology assessment program. Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research. 2010, 13 (8): 867-872. 10.1111/j.1524-4733.2010.00788.x.CrossRef
9.
go back to reference Bhandari A, Wagner T: Self-reported utilization of health care services: improving measurement and accuracy. Med Care Res Rev. 2006, 63 (2): 217-235. 10.1177/1077558705285298.CrossRefPubMed Bhandari A, Wagner T: Self-reported utilization of health care services: improving measurement and accuracy. Med Care Res Rev. 2006, 63 (2): 217-235. 10.1177/1077558705285298.CrossRefPubMed
10.
go back to reference Schweikert B, Hahmann H, Leidl R: Development and first assessment of a questionnaire for health care utilization and costs for cardiac patients. BMC Health Serv Res. 2008, 8: 187-10.1186/1472-6963-8-187.CrossRefPubMedPubMedCentral Schweikert B, Hahmann H, Leidl R: Development and first assessment of a questionnaire for health care utilization and costs for cardiac patients. BMC Health Serv Res. 2008, 8: 187-10.1186/1472-6963-8-187.CrossRefPubMedPubMedCentral
11.
go back to reference Johnston K, Buxton MJ, Jones DR, Fitzpatrick R: Assessing the costs of healthcare technologies in clinical trials. Health Technol Assess. 1999, 3 (6): 1-76.PubMed Johnston K, Buxton MJ, Jones DR, Fitzpatrick R: Assessing the costs of healthcare technologies in clinical trials. Health Technol Assess. 1999, 3 (6): 1-76.PubMed
12.
go back to reference O'Sullivan AK, Thompson D, Drummond MF: Collection of health-economic data alongside clinical trials: is there a future for piggyback evaluations?. Value Health. 2005, 8 (1): 67-79. 10.1111/j.1524-4733.2005.03065.x.CrossRefPubMed O'Sullivan AK, Thompson D, Drummond MF: Collection of health-economic data alongside clinical trials: is there a future for piggyback evaluations?. Value Health. 2005, 8 (1): 67-79. 10.1111/j.1524-4733.2005.03065.x.CrossRefPubMed
13.
go back to reference Clarke PM, Fiebig DG, Gerdtham UG: Optimal recall length in survey design. J Health Econ. 2008, 27 (5): 1275-1284. 10.1016/j.jhealeco.2008.05.012.CrossRefPubMed Clarke PM, Fiebig DG, Gerdtham UG: Optimal recall length in survey design. J Health Econ. 2008, 27 (5): 1275-1284. 10.1016/j.jhealeco.2008.05.012.CrossRefPubMed
14.
go back to reference Goossens ME, Rutten-van Molken MP, Vlaeyen JW, van der Linden SM: The cost diary: a method to measure direct and indirect costs in cost-effectiveness research. J Clin Epidemiol. 2000, 53 (7): 688-695. 10.1016/S0895-4356(99)00177-8.CrossRefPubMed Goossens ME, Rutten-van Molken MP, Vlaeyen JW, van der Linden SM: The cost diary: a method to measure direct and indirect costs in cost-effectiveness research. J Clin Epidemiol. 2000, 53 (7): 688-695. 10.1016/S0895-4356(99)00177-8.CrossRefPubMed
15.
go back to reference Clark RE, Teague GB, Ricketts SK, Bush PW, Keller AM, Zubkoff M, Drake RE: Measuring resource use in economic evaluations: determining the social costs of mental illness. J Ment Health Adm. 1994, 21 (1): 32-41. 10.1007/BF02521343.CrossRefPubMed Clark RE, Teague GB, Ricketts SK, Bush PW, Keller AM, Zubkoff M, Drake RE: Measuring resource use in economic evaluations: determining the social costs of mental illness. J Ment Health Adm. 1994, 21 (1): 32-41. 10.1007/BF02521343.CrossRefPubMed
16.
go back to reference Heinrich S, Luppa M, Matschinger H, Angermeyer MC, Riedel-Heller SG, Konig HH: Service utilization and health-care costs in the advanced elderly. Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research. 2008, 11 (4): 611-620. 10.1111/j.1524-4733.2007.00285.x.CrossRef Heinrich S, Luppa M, Matschinger H, Angermeyer MC, Riedel-Heller SG, Konig HH: Service utilization and health-care costs in the advanced elderly. Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research. 2008, 11 (4): 611-620. 10.1111/j.1524-4733.2007.00285.x.CrossRef
17.
go back to reference van Roijen LH, van Straten A, Al M, Rutten F, Donker M: Cost-utility of brief psychological treatment for depression and anxiety. Br J Psychiatry. 2006, 188: 323-329. 10.1192/bjp.188.4.323.CrossRefPubMed van Roijen LH, van Straten A, Al M, Rutten F, Donker M: Cost-utility of brief psychological treatment for depression and anxiety. Br J Psychiatry. 2006, 188: 323-329. 10.1192/bjp.188.4.323.CrossRefPubMed
18.
go back to reference Kimman ML, Dirksen CD, Voogd AC, Falger P, Gijsen BC, Thuring M, Lenssen A, van der Ent F, Verkeyn J, Haekens C, et al: Economic evaluation of four follow-up strategies after curative treatment for breast cancer: results of an RCT. Eur J Cancer. 2011, 47 (8): 1175-1185. 10.1016/j.ejca.2010.12.017.CrossRefPubMed Kimman ML, Dirksen CD, Voogd AC, Falger P, Gijsen BC, Thuring M, Lenssen A, van der Ent F, Verkeyn J, Haekens C, et al: Economic evaluation of four follow-up strategies after curative treatment for breast cancer: results of an RCT. Eur J Cancer. 2011, 47 (8): 1175-1185. 10.1016/j.ejca.2010.12.017.CrossRefPubMed
19.
go back to reference Kirchberger I, Meisinger C, Seidl H, Wende R, Kuch B, Holle R: Nurse-based case management for aged patients with myocardial infarction: study protocol of a randomized controlled trial. BMC Geriatr. 2010, 10: 29-10.1186/1471-2318-10-29.CrossRefPubMedPubMedCentral Kirchberger I, Meisinger C, Seidl H, Wende R, Kuch B, Holle R: Nurse-based case management for aged patients with myocardial infarction: study protocol of a randomized controlled trial. BMC Geriatr. 2010, 10: 29-10.1186/1471-2318-10-29.CrossRefPubMedPubMedCentral
20.
go back to reference Tan SS, Rutten FF, van Ineveld BM, Redekop WK, Hakkaart-van Roijen L: Comparing methodologies for the cost estimation of hospital services. The European journal of health economics: HEPAC: health economics in prevention and care. 2009, 10 (1): 39-45.CrossRefPubMed Tan SS, Rutten FF, van Ineveld BM, Redekop WK, Hakkaart-van Roijen L: Comparing methodologies for the cost estimation of hospital services. The European journal of health economics: HEPAC: health economics in prevention and care. 2009, 10 (1): 39-45.CrossRefPubMed
21.
go back to reference Coyle D, Lee KM: The problem of protocol driven costs in pharmacoeconomic analysis. Pharmacoeconomics. 1998, 14 (4): 357-363. 10.2165/00019053-199814040-00003.CrossRefPubMed Coyle D, Lee KM: The problem of protocol driven costs in pharmacoeconomic analysis. Pharmacoeconomics. 1998, 14 (4): 357-363. 10.2165/00019053-199814040-00003.CrossRefPubMed
22.
go back to reference Mühlberger N, Behrend C, Stark R, Holle R: Database-supported identification and entry of drug data in health studies - experience with the IDOM software [datenbankgestützte online-erfassung von arzneimitteln im rahmen gesundheitswissenschaftlicher studien erfahrungen mit der IDOM-software] in German. Informatik Biometrie und Epidemiologie in Medizin und Biologie. 2003, 34 (4): 601-611. Mühlberger N, Behrend C, Stark R, Holle R: Database-supported identification and entry of drug data in health studies - experience with the IDOM software [datenbankgestützte online-erfassung von arzneimitteln im rahmen gesundheitswissenschaftlicher studien erfahrungen mit der IDOM-software] in German. Informatik Biometrie und Epidemiologie in Medizin und Biologie. 2003, 34 (4): 601-611.
24.
go back to reference Krauth C, Hessel F, Hansmeier T, Wasem J, Seitz R, Schweikert B: Empirical standard costs for health economic evaluation in Germany – a proposal by the working group methods in health economic evaluation. Gesundheitswesen. 2005, 67 (10): 736-746. 10.1055/s-2005-858698.CrossRefPubMed Krauth C, Hessel F, Hansmeier T, Wasem J, Seitz R, Schweikert B: Empirical standard costs for health economic evaluation in Germany – a proposal by the working group methods in health economic evaluation. Gesundheitswesen. 2005, 67 (10): 736-746. 10.1055/s-2005-858698.CrossRefPubMed
28.
go back to reference Statistical yearbook 2010 for the federal republic of germany including 'international tables'. Edited by: Office FS. 2010, Wiesbaden: Federal Statistical Office Statistical yearbook 2010 for the federal republic of germany including 'international tables'. Edited by: Office FS. 2010, Wiesbaden: Federal Statistical Office
34.
go back to reference Briggs AH, Gray AM: Power and sample size calculations for stochastic cost-effectiveness analysis. Medical decision making: an international journal of the Society for Medical Decision Making. 1998, 18 (2 Suppl): S81-S92.CrossRef Briggs AH, Gray AM: Power and sample size calculations for stochastic cost-effectiveness analysis. Medical decision making: an international journal of the Society for Medical Decision Making. 1998, 18 (2 Suppl): S81-S92.CrossRef
35.
go back to reference Hamm CW: Guidelines: acute coronary syndrome (ACS). II: acute coronary syndrome with ST-elevation. Z Kardiol. 2004, 93 (4): 324-341. 10.1007/s00392-004-0109-x.CrossRefPubMed Hamm CW: Guidelines: acute coronary syndrome (ACS). II: acute coronary syndrome with ST-elevation. Z Kardiol. 2004, 93 (4): 324-341. 10.1007/s00392-004-0109-x.CrossRefPubMed
36.
go back to reference Hamm CW: Guidelines: acute coronary syndrome (ACS). 1: ACS without persistent ST segment elevations. Z Kardiol. 2004, 93 (1): 72-90. 10.1007/s00392-004-1064-2.CrossRefPubMed Hamm CW: Guidelines: acute coronary syndrome (ACS). 1: ACS without persistent ST segment elevations. Z Kardiol. 2004, 93 (1): 72-90. 10.1007/s00392-004-1064-2.CrossRefPubMed
37.
go back to reference Barber JA, Thompson SG: Analysis and interpretation of cost data in randomised controlled trials: review of published studies. BMJ. 1998, 317 (7167): 1195-1200. 10.1136/bmj.317.7167.1195.CrossRefPubMedPubMedCentral Barber JA, Thompson SG: Analysis and interpretation of cost data in randomised controlled trials: review of published studies. BMJ. 1998, 317 (7167): 1195-1200. 10.1136/bmj.317.7167.1195.CrossRefPubMedPubMedCentral
Metadata
Title
Empirical analysis shows reduced cost data collection may be an efficient method in economic clinical trials
Authors
Hildegard Seidl
Christa Meisinger
Rupert Wende
Rolf Holle
Publication date
01-12-2012
Publisher
BioMed Central
Published in
BMC Health Services Research / Issue 1/2012
Electronic ISSN: 1472-6963
DOI
https://doi.org/10.1186/1472-6963-12-318

Other articles of this Issue 1/2012

BMC Health Services Research 1/2012 Go to the issue